Rachel combines a strong scientific background with more than ten years of experience in market access consulting.

Rachel has over a decade of experience in market access consultancy, working across pharmaceuticals, medical devices, drug-device combinations and digital health. Her therapy area expertise is varied and includes dermatology, rare diseases, oncology, HIV and NASH.

In previous roles she has been responsible for providing strategic oversight to research projects to ensure overall objectives were met. She has extensive project experience that ranges from mapping and understanding the European market for medical devices and diagnostics, including TPP testing, product positioning, HTA and reimbursement landscapes, procurement routes and price potential.

‍

"I am driven by the challenge of identifying and communicating the value of newly developed drugs and devices to ensure maximum access for those in need"